Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 5
2004 3
2005 10
2006 2
2007 1
2008 7
2009 9
2010 10
2011 10
2012 20
2013 15
2014 15
2015 14
2016 17
2017 17
2018 22
2019 19
2020 17
Text availability
Article attribute
Article type
Publication date

Search Results

199 results
Results by year
Filters applied: . Clear all
Page 1
Single-cell CAS-seq reveals a class of short PIWI-interacting RNAs in human oocytes.
Yang Q, Li R, Lyu Q, Hou L, Liu Z, Sun Q, Liu M, Shi H, Xu B, Yin M, Yan Z, Huang Y, Liu M, Li Y, Wu L. Yang Q, et al. Among authors: hou l. Nat Commun. 2019 Jul 29;10(1):3389. doi: 10.1038/s41467-019-11312-8. Nat Commun. 2019. PMID: 31358756 Free PMC article.
Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer.
Liu X, Lu Y, Xu Y, Hou S, Huang J, Wang B, Zhao J, Xia S, Fan S, Yu X, Du Y, Hou L, Li Z, Ding Z, An S, Huang B, Li L, Tang J, Ju J, Guan H, Song B. Liu X, et al. Among authors: hou l. Cancer Lett. 2019 Sep 10;459:122-134. doi: 10.1016/j.canlet.2019.05.035. Epub 2019 Jun 5. Cancer Lett. 2019. PMID: 31173853
Incidence and risk of hematologic toxicities with hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukopenia: A systematic review and meta-analysis.
Gao C, Wang J, Li Y, Zhao H, Li R, Hou L, Zhang Y, Tian S, Liang H, Wang C, Chen X, Wang J. Gao C, et al. Among authors: hou l. Medicine (Baltimore). 2018 Aug;97(34):e11860. doi: 10.1097/MD.0000000000011860. Medicine (Baltimore). 2018. PMID: 30142779 Free PMC article. Review.
A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID.
Xu YC, Liu X, Li M, Li Y, Li CY, Lu Y, Sanches J, Wang L, Du Y, Mao LM, Zuo SB, Liu HT, Shen J, Wang B, Hou L, Li LH, Tang JW, Ju JF, Guan HW, Song B. Xu YC, et al. Among authors: hou l. Mol Ther Nucleic Acids. 2018 Sep 7;12:578-590. doi: 10.1016/j.omtn.2018.06.011. Epub 2018 Jul 5. Mol Ther Nucleic Acids. 2018. PMID: 30195794 Free PMC article.
Identifying RNA Biomarkers for Oesophageal Squamous Cell Carcinoma.
Zheng S, Li J, Hou L, Li J. Zheng S, et al. Among authors: hou l. Stud Health Technol Inform. 2019 Aug 21;264:1084-1088. doi: 10.3233/SHTI190392. Stud Health Technol Inform. 2019. PMID: 31438092
miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD.
Sanches JGP, Xu Y, Yabasin IB, Li M, Lu Y, Xiu X, Wang L, Mao L, Shen J, Wang B, Hou L, Ju J, Zhao J, Song B. Sanches JGP, et al. Among authors: hou l. Chem Biol Interact. 2018 Apr 1;285:85-95. doi: 10.1016/j.cbi.2018.02.024. Epub 2018 Feb 23. Chem Biol Interact. 2018. PMID: 29477382
Chinese Herbal Medicine (Xiaoaiping) Injections for Chemotherapy-Induced Thrombocytopenia: A Randomized, Controlled, Multicenter Clinical Trial.
Qi S, Li X, Dong Q, Lai H, Porter D, Tian S, Hou L, Chen X, Li X, Wang K. Qi S, et al. Among authors: hou l. J Altern Complement Med. 2019 Jun;25(6):648-655. doi: 10.1089/acm.2018.0470. Epub 2019 May 17. J Altern Complement Med. 2019. PMID: 31090434 Free PMC article. Clinical Trial.
Targeted thrombolysis by using c-RGD-modified N,N,N-Trimethyl Chitosan nanoparticles loaded with lumbrokinase.
Liao J, Ren X, Yang B, Li H, Zhang Y, Yin Z. Liao J, et al. Among authors: li h. Drug Dev Ind Pharm. 2019 Jan;45(1):88-95. doi: 10.1080/03639045.2018.1522324. Epub 2018 Oct 8. Drug Dev Ind Pharm. 2019. PMID: 30198790
Mining and standardizing chinese consumer health terms.
Hou L, Kang H, Liu Y, Li L, Li J. Hou L, et al. BMC Med Inform Decis Mak. 2018 Dec 7;18(Suppl 5):120. doi: 10.1186/s12911-018-0695-6. BMC Med Inform Decis Mak. 2018. PMID: 30526591 Free PMC article.
199 results
Jump to page